RXRX Recursion Pharmaceuticals, Inc.

RXRX Recursion Pharmaceuticals, Inc.

Healthcare · Biotechnology

Desk view

PassedLOTTERY (pre-commercial): clinical-stage AI drug-discovery platform; the desk's biotech capital-cycle section files it among the 'lottery tickets' (cash-burning, needs ROI proof). Latest 10-Q on file (quarter ended 2026-03-31, unreconciled EDGAR key-financials): revenue $6.5M against an operating loss of $128.5M. Tape: vwap reclaim verified (price +1.0% vs VWAP, 30D +35.4%) but 1Y -26.2% (alpha vs SPY -42.2%), 3Y -35.5%: no durable uptrend to hold. (2026-10-09)
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $3.41 · VWAP $4.17 · -16.9% vs 12m avg buyer

pullback vol: expandinggaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster Director + 1 other sold $367K, Oct 7

Coverage

2 watchlists

RXRX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist RXRX belongs to, members best 30-day change first — RXRX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
@biotech-scan

Desk commentary

Authored analysis and challenge notes tied to RXRX.

1

Next earnings RXRX reports in 18 days Nov 4

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $8M, diluted EPS -$0.25, net income -$131M (SEC filing). Across the print the stock moved -3.9% (close before → first close after).

full note →

Against street estimates

How RXRX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 -0.23-0.25-6.8%Miss
May 6 -0.26-0.22+14.4%Beat
Feb 25 -0.32-0.21+33.3%Beat
Nov 5 '25 -0.38-0.36+5.7%Beat
Aug 5 '25 -0.35-0.41-16.0%Miss
May 5 '25 -0.52-0.50+3.1%Beat
Feb 28 '25 -0.42-0.53-27.2%Miss
Nov 6 '24 -0.33-0.34-2.1%Miss

Recent news

Headlines about RXRX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled today · Oct 17

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 5 Catalyst RXRX earnings
May 6 Catalyst RXRX earnings
May 5 Catalyst RXRX earnings
Apr 20 Discord $IBRX and $RXRX ?